- (PLX AI) – Investors should buy Coloplast shares as the Atos Medical acquisition fits perfectly from both a business - and business-culture perspective, analysts at Kepler Cheuvreux said.
- • Kepler previously rated Coloplast hold
- • Price target raised to DKK 1,300 from DKK 1,150
- • Coloplast is entering another high-growth market with Atos Medical, and the business integration from Q2 bridges the time until data from clinical studies and new launches, Kepler said
- • Shares rose 2% today
Quelle: PLX AI